Search Results - "MOLANDER, L"

Refine Results
  1. 1

    In the shadow of the Cosmetic Directive — Inconsistencies in EU environmental hazard classification requirements for UV-filters by Sobek, A., Bejgarn, S., Rudén, C., Molander, L., Breitholtz, M.

    Published in The Science of the total environment (01-09-2013)
    “…UV-filters are chemicals with potentially environmental hazardous properties. In the European Union (EU), UV-filters contained in sunscreen products are…”
    Get full text
    Journal Article
  2. 2

    Blood pressure change and antihypertensive treatment in old and very old people: evidence of age, sex and cohort effects by Molander, L, Lövheim, H

    Published in Journal of human hypertension (01-03-2013)
    “…The epidemiology of blood pressure in very old age has not been thoroughly studied. The objective of this study was to study blood pressure changes throughout…”
    Get full text
    Journal Article
  3. 3
  4. 4

    cis-pinic acid, a possible precursor for organic aerosol formation from ozonolysis of α-pinene by Christoffersen, T.S, Hjorth, J, Horie, O, Jensen, N.R, Kotzias, D, Molander, L.L, Neeb, P, Ruppert, L, Winterhalter, R, Virkkula, A, Wirtz, K, Larsen, B.R

    Published in Atmospheric environment (1994) (01-05-1998)
    “…A method for the analysis of carboxylic acids in aerosols was developed, based on the collection of particles on Teflon filters (2.5 cm diameter with a 0.4 μm…”
    Get full text
    Journal Article
  5. 5

    Pharmacokinetic investigation of a nicotine sublingual tablet by MOLANDER, L, LUNELL, E

    “…To evaluate the pharmacokinetics of a new 2-mg nicotine sublingual tablet under varying conditions of use. The pharmacokinetics of the 2-mg nicotine sublingual…”
    Get full text
    Journal Article
  6. 6

    Site of nicotine absorption from a vapour inhaler: comparison with cigarette smoking by LUNELL, E, MOLANDER, L, EKBERG, K, WAHREN, J

    Published in European journal of clinical pharmacology (01-01-2000)
    “…The aim of the study was to assess the site of nicotine absorption during and after use of a nicotine-vapour inhaler compared with that after cigarette…”
    Get full text
    Journal Article
  7. 7

    Pharmacokinetics of nicotine in kidney failure by Molander, Lars, Hansson, Anna, Lunell, Erik, Alainentalo, Lisbeth, Hoffmann, Mikael, Larsson, Rutger

    Published in Clinical pharmacology and therapeutics (01-09-2000)
    “…Background Smoking is an important risk factor for cardiovascular and cerebrovascular complications in patients with chronic kidney failure. Very high plasma…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Testing and refining the Science in Risk Assessment and Policy (SciRAP) web‐based platform for evaluating the reliability and relevance of in vivo toxicity studies by Beronius, Anna, Molander, Linda, Zilliacus, Johanna, Rudén, Christina, Hanberg, Annika

    Published in Journal of applied toxicology (01-12-2018)
    “…The Science in Risk Assessment and Policy (SciRAP) web‐based platform was developed to promote and facilitate structure and transparency in the evaluation of…”
    Get full text
    Journal Article
  10. 10

    Facilitating the use of non-standard in vivo studies in health risk assessment of chemicals: a proposal to improve evaluation criteria and reporting by Beronius, Anna, Molander, Linda, Rudén, Christina, Hanberg, Annika

    Published in Journal of applied toxicology (01-06-2014)
    “…ABSTRACT To improve data availability in health risk assessment of chemicals and fill information gaps there is a need to facilitate the use of non‐standard…”
    Get full text
    Journal Article
  11. 11

    Temperature dependency of the release and bioavailability of nicotine from a nicotine vapour inhaler; in vitro/in vivo correlation by LUNELL, E, MOLANDER, L, ANDERSSON, S.-B

    Published in European journal of clinical pharmacology (01-09-1997)
    “…To investigate the temperature dependency of the dose released and the plasma levels of nicotine from a vapour inhaler. In an open, randomised, three-way…”
    Get full text
    Journal Article
  12. 12

    Science in Risk Assessment and Policy (SciRAP): An Online Resource for Evaluating and Reporting In Vivo (Eco)Toxicity Studies by Molander, Linda, Ågerstrand, Marlene, Beronius, Anna, Hanberg, Annika, Rudén, Christina

    Published in Human and ecological risk assessment (03-04-2015)
    “…(Eco)toxicity studies conducted according to internationally standardized test guidelines are often considered reliable by default and preferred as key…”
    Get full text
    Journal Article
  13. 13

    Relative bioavailability of nicotine from a nasal spray in infectious rhinitis and after use of a topical decongestant by LUNELL, E, MOLANDER, L, ANDERSSON, M

    Published in European journal of clinical pharmacology (01-03-1995)
    “…The relative bioavailability of nicotine from a nasal spray was assessed in 15 smokers suffering a common cold and rhinitis according to generally accepted…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Low frequency of RET mutations in Hirschsprung disease in Sweden by Svensson, Pär-Johan, Molander, Marie-Louise, Eng, Charis, Anvret, Maria, Nordenskjöld, Agneta

    Published in Clinical genetics (01-07-1998)
    “…Hirschsprung disease is a congenital malformation, where absence of intramural ganglia in the hindgut results in a defect in the coordination of peristaltic…”
    Get full text
    Journal Article
  16. 16

    Combining web‐based tools for transparent evaluation of data for risk assessment: developmental effects of bisphenol A on the mammary gland as a case study by Molander, Linda, Hanberg, Annika, Rudén, Christina, Ågerstrand, Marlene, Beronius, Anna

    Published in Journal of applied toxicology (01-03-2017)
    “…Different tools have been developed that facilitate systematic and transparent evaluation and handling of toxicity data in the risk assessment process. The…”
    Get full text
    Journal Article
  17. 17

    A heterozygous frameshift mutation in the endothelin-3 (EDN-3) gene in isolated Hirschsprung's disease by SVENSSON, P.-J, VON TELL, D, MOLANDER, M.-L, ANVRET, M, NORDENSKJÖLD, A

    Published in Pediatric research (01-05-1999)
    “…Hirschsprung's disease, affecting one in 5000 live newborns, is the most common cause of neonatal intestinal obstruction. The obstruction or, later in life,…”
    Get full text
    Journal Article
  18. 18

    Phenotypic variation in a family with mutations in two Hirschsprung-related genes (RET and endothelin receptor B) by SVENSSON, P.-J, ANVRET, M, MOLANDER, M.-L, NORDENSKJÖLD, A

    Published in Human genetics (01-08-1998)
    “…Hirschsprung disease is a congenital malformation affecting 1 in 5000 live births. The absence of parasympathetic neuronal ganglia (Meissner, Auerbach) in the…”
    Get full text
    Journal Article
  19. 19

    Effect of nicotine vapour inhalation of the relief of tobacco withdrawal symptoms by LUNELL, E, MOLANDER, L, LEISCHOW, S. J, FAGERSTRÖM, K.-O

    Published in European journal of clinical pharmacology (01-07-1995)
    “…Fifteen subjects participated in a randomised, placebo-controlled cross-over study to assess the effect of a nicotine vapour inhaler on craving and other…”
    Get full text
    Journal Article
  20. 20

    WikiPharma – A freely available, easily accessible, interactive and comprehensive database for environmental effect data for pharmaceuticals by Molander, Linda, Ågerstrand, Marlene, Rudén, Christina

    Published in Regulatory toxicology and pharmacology (01-12-2009)
    “…A significant number of Active Pharmaceutical Ingredients (APIs) have been identified in the environment and in surface waters. Data on the environmental…”
    Get full text
    Journal Article